Skip to main content
. 2022 Aug 3;23(15):8606. doi: 10.3390/ijms23158606

Table 1.

Phases of COVID-19 infection and the corresponding treatment approach.

Infection Phase Clinical Presentation Treatment Approach Sources
Viral replication Upper respiratory tract infection, fever, muscle fatigue, pain Antiviral agents are used to decrease viral load, transmission, and prevent progression to the next phases of the disease [10,11,12]
Immune hyperactivation Dyspnea, pneumonia, vasculopathy, acute cardiac and renal
damage, sepsis, secondary infections
Monoclonal antibodies, anti-coagulants, immunosuppressants, oxygen, antiviral drugs
Post-Acute Sequelae of COVID-19 Fatigue, headache, dyspnea, and anosmia Immunosuppressants, convalescent plasma therapy [13,14,15]